HuagongsheHuagongshe Chemistry Print Report · For research reference only
Piperazine → (1R,2S)-2-(4-chlorophenyl)-1'-(3-(piperazine-1-carbonyl)benzyl)spiro[cyclopropane-1,3'-indolin]-2'-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | HCID 53244689 | HCID 53244689 | — |
| Product | (1R,2S)-2-(4-chlorophenyl)-1'-(3-(piperazine-1-carbonyl)benzyl)spiro[cyclopropane-1,3'-indolin]-2'-one | HCID 58305274 | — |
Reaction Steps
The title compound was prepared in analogy to Example 60 starting from piperazine, (3-bromomethyl)-benzoate (commercially available), (1R,2S) and (1S,2R)-3-((2-(4-chlorophenyl)-2′-oxospiro[cyclopropane-1,3′-indoline]-1′-yl)methyl)benzoic acid prepared as in Scheme 1. LC/MS m/e calcd. for C28H26ClN3O2: 471, observed (M+H)+: 472.2 1H NMR (400 MHz, MeOD-d4) δppm 2.17-2.30 (m, 2 H) 3.51 (br. s., 8 H) 3.21-3.35 (m, 1 H) 5.04-5.23 (m, 2 H) 6.10 (d, J=7.58 Hz, 1 H) 6.74 (t, J=7.45 Hz, 1 H) 6.95 (d, J=7.83 Hz, 1 H) 7.05-7.16 (m, 1 H) 7.23 (d, J=8.34 Hz, 2 H) 7.29-7.38 (m, 2 H) 7.40-7.49 (m, 2 H) 7.49-7.58 (m, 2 H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08354443B2 |
| Source dataset | uspto-grants-2013_01 |
| ORD ID | ord-6f8e0e39485b435898fe23dac3c996f5 |
| Source note | uspto-grants-2013_01 |